VIENNA — AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. Read More
Source link
As New Mexico jury finds Meta platforms harm children, social media firms await more legal decisions
SAN FRANCISCO (AP) — The first jury verdict in a series of social media child safety trials this year is in — and it’s not looking good for Meta. A…








